James Q. Del Rosso, DO, FAOCD, Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada Sanjay Bhambri, DO, Chief Dermatology Resident (PGY-4), Valley Hospital Medical Center, Las Vegas, Nevada
Roger Ceilley, MD, University of Iowa, Department of Dermatology, Iowa City, Iowa Andrew Eisenthal, BS, Bucknell University, Lewisburg, Pennsylvania
Sherrie J. Divito, PhD; Justin M. Haught, MD; Joseph C. English, III, MD; Laura K. Ferris, MD, PhD Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Abstract Dermonecrotic
Sharon E. Jacob, MD; Andrew D. Breithaupt, BA Department of Dermatology and Cutaneous Surgery, University of California San Diego, San Diego, California Abstract This article presents the case of a
James Q. Del Rosso, DO, FAOCD
Dear Editor: A recently published “comprehensive update” of therapies directed toward actinic keratoses (AKs)[1] does, in its final sentence, mention “dermabrasion has been demonstrated to provide long-term (5-year) clearance of
Harry James Hurley Jr., 82, practicing dermatologist for 56 years and past president of the American Dermatological Association, died of multiple myeloma Sunday, July 26, 2009. During his career, Dr.